Drugs / Bergamot Essential Oil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07384312 Comparator | Oct 2023 → Dec 2024 | depressive disorder | Dongdong Qin | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bergamot Essential Oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07384312 ↗ |
| Known as | BEO | “The control group received BEO inhalation therapy, during which one drop (0.05 mL per drop) of 10% mandarin essential oil was administered into the aroma diffuser using a...” NCT07384312 ↗ |
| Route | Inhaled | “BEO inhalation therapy” NCT07384312 ↗ |